0
Signin
countryflagCA

888-969-2592

RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%

Extendicare Inc

Healthcare CA EXE

10.32CAD
0.08(0.78%)

Last update at 2024-11-21T19:27:00Z

Day Range

10.1610.34
LowHigh

52 Week Range

6.059.63
LowHigh

Fundamentals

  • Previous Close 10.24
  • Market Cap798.78M
  • Volume77250
  • P/E Ratio14.07
  • Dividend Yield5.02%
  • EBITDA99.78M
  • Revenue TTM1388.29M
  • Revenue Per Share TTM16.45
  • Gross Profit TTM 108.53M
  • Diluted EPS TTM0.68

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.49600M 16.04M 58.87M 24.24M 12.32M
Minority interest - - - - -
Net income -4.51100M 9.01M 42.59M 17.05M 31.74M
Selling general administrative 1164.12M 1140.20M 48.96M 42.34M 39.75M
Selling and marketing expenses - - - - -
Gross profit 1221.58M 1216.76M 1158.29M 1131.95M 133.98M
Reconciled depreciation 32.12M 38.57M 38.80M 39.59M 35.27M
Ebit 20.99M 56.62M 93.30M 52.39M 63.56M
Ebitda 53.11M 95.19M 132.10M 91.98M 98.83M
Depreciation and amortization 32.12M 38.57M 38.80M 39.59M 35.27M
Non operating income net other - - - - -
Operating income 20.99M 56.62M 93.30M 52.39M 38.77M
Other operating expenses 1196.91M 1162.01M 1063.95M 1080.43M 1061.04M
Interest expense 20.61M 27.20M 28.48M 28.73M 27.58M
Tax provision 0.01M 7.03M 16.28M 7.18M 4.24M
Interest income 15.52M 23.74M 28.97M 23.04M 22.62M
Net interest income -15.28200M -25.03200M -27.03400M -26.88800M -26.70100M
Extraordinary items 74.06M 2.49M 11.60M 11.58M 23.65M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.01M 7.03M 16.28M 7.18M 4.24M
Total revenue 1221.58M 1216.76M 1158.29M 1131.95M 1120.01M
Total operating expenses 1196.91M 1162.01M 1063.95M 1080.43M 1061.04M
Cost of revenue 1113.05M 1070.41M 976.20M 998.50M 986.02M
Total other income expense net -25.48300M -40.58000M -34.43100M -28.15500M -26.45400M
Discontinued operations 74.06M 2.49M 11.60M 13.83M 23.65M
Net income from continuing ops -4.51100M 9.01M 42.59M 17.05M 8.08M
Net income applicable to common shares 69.55M 11.50M 54.19M 28.63M 31.74M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 672.73M 781.58M 900.32M 963.13M 888.80M
Intangible assets 78.46M 51.21M 46.63M 36.50M 38.20M
Earning assets - - - - -
Other current assets 20.20M 23.98M 26.47M 40.23M 20.66M
Total liab 584.81M 680.88M 798.40M 834.94M 773.39M
Total stockholder equity 87.92M 100.70M 101.92M 128.19M 115.41M
Deferred long term liab - - - - -
Other current liab 3.25M 5.61M 15.34M 21.06M 5.18M
Common stock 467.35M 475.42M 500.88M 500.58M 498.12M
Capital stock 467.35M 475.42M 500.88M 500.58M 498.12M
Retained earnings -393.47100M -384.62000M -402.45300M -370.96300M -382.18900M
Other liab - 41.16M 52.48M 59.64M 74.28M
Good will 45.85M 45.85M 45.85M 51.67M 51.67M
Other assets 0.00000M 37.76M 47.32M 52.96M 84.50M
Cash 75.91M 167.28M 104.63M 179.96M 94.46M
Cash and equivalents - 167.28M 104.63M 179.96M 94.46M
Total current liabilities 226.39M 274.99M 281.91M 279.52M 275.87M
Current deferred revenue - - - - -
Net debt 258.60M 216.69M 432.22M 384.64M 556.31M
Short term debt 19.88M 19.24M 73.58M 71.39M 133.77M
Short long term debt 19.88M 19.24M 73.58M 71.39M 133.77M
Short long term debt total 334.52M 383.97M 536.85M 564.60M 556.31M
Other stockholder equity 13.09M 17.70M 15.27M 12.00M 10.76M
Property plant equipment - 388.72M 535.60M 525.90M 530.53M
Total current assets 187.14M 258.04M 224.92M 296.08M 183.90M
Long term investments 24.53M - - - -
Net tangible assets - 3.64M 9.44M 40.01M 25.54M
Short term investments - - - - -
Net receivables 91.03M 64.07M 83.54M 73.39M 66.34M
Long term debt 314.64M 364.74M 463.27M 493.21M 422.54M
Inventory - 2.70M 10.29M 2.51M 2.44M
Accounts payable 203.26M 250.14M 192.99M 187.07M 136.92M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.96M -7.79800M -11.76800M -13.42700M -11.27300M
Additional paid in capital - - - - -
Common stock total equity - - - 500.58M 498.12M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 34.98M 30.47M 32.89M 37.13M 71.75M
Deferred long term asset charges - - - - -
Non current assets total 485.59M 523.54M 675.40M 667.04M 704.90M
Capital lease obligations - - - - -
Long term debt total - 364.74M 463.27M 493.21M 422.54M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 155.64M -63.73300M 2.00M 12.77M -55.05200M
Change to liabilities 48.62M 15.45M 49.85M -5.11100M 2.21M
Total cashflows from investing activities 155.64M -63.73300M 2.00M 12.77M -55.05200M
Net borrowings -114.22900M -29.98200M 6.96M 10.33M 0.32M
Total cash from financing activities -191.85900M -74.83600M -38.16300M -28.66800M -48.76300M
Change to operating activities 1.40M 11.95M -19.85500M 1.13M -0.53600M
Net income 69.55M 11.50M 54.19M 28.63M 31.74M
Change in cash 62.65M -75.32900M 85.50M 28.56M -62.26300M
Begin period cash flow 104.63M 179.96M 94.46M 65.89M 128.16M
End period cash flow 167.28M 104.63M 179.96M 94.46M 65.89M
Total cash from operating activities 98.71M 63.42M 121.27M 45.19M 39.47M
Issuance of capital stock - - - - -
Depreciation 32.12M 38.57M 38.80M 39.59M 35.27M
Other cashflows from investing activities 257.27M 5.79M 35.10M 45.95M 29.36M
Dividends paid 42.55M 42.99M 41.26M 37.22M 37.42M
Change to inventory - - - - -
Change to account receivables 4.04M -13.76500M -7.94600M 0.20M -8.17200M
Sale purchase of stock -35.02300M - - 0.00000M -6.25800M
Other cashflows from financing activities 1.31M 0.48M 58.50M 44.21M 147.52M
Change to netincome -57.02500M -0.28300M 6.23M -19.25200M -21.03700M
Capital expenditures 101.63M 69.52M 33.10M 33.18M 50.65M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 54.06M 13.63M 22.05M -4.83300M -6.49800M
Stock based compensation 2.64M 3.57M 2.00M 1.60M 0.43M
Other non cash items -59.61900M -10.45900M -12.34800M -26.98000M -19.80300M
Free cash flow -2.91500M -6.09900M 88.17M 12.01M -11.17500M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EXE
Extendicare Inc		 0.08 0.78% 10.32 14.07 15.70 0.58 7.49 0.71 7.52
DNTL
dentalcorp Holdings Ltd		 -0.12 1.28% 9.23 - 19.68 1.33 1.14 2.21 15.05
SIA
Sienna Senior Living Inc		 - -% 16.99 43.79 36.90 1.67 3.83 2.82 18.48
WELL
WELL Health Technologies Corp		 0.07 1.36% 5.21 17.23 18.12 1.39 1.42 1.78 5.49
DR
Medical Facilities Corporation		 -0.09 0.58% 15.46 13.28 11.57 0.80 3.14 0.73 3.02

Reports Covered

Stock Research & News

View All

Profile

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Extendicare Inc

3000 Steeles Avenue East, Markham, ON, Canada, L3R 4T9

Key Executives

Name Title Year Born
Dr. Michael R. Guerriere M.D., MBA CEO, Pres & Director 1964
Mr. David E. Bacon Sr. VP & CFO NA
Mr. John Toffoletto Sr. VP, Chief Legal Officer & Corp. Sec. NA
Ms. Leslie Sarauer Sr. VP & Chief HR Officer 1962
Mr. Ali Mohammad Mir VP, ParaMed Operations NA
Mr. Steve Paraskevopoulos Sr. VP of ParaMed & CTO NA
Ms. Jillian E. Fountain VP of Investor Relations NA
Ms. Lisa Pearson VP of Public Affairs NA
Ms. Elaine E. Everson VP of Corp. Devel. NA
Dr. Matthew Morgan Chief Medical Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.